A Phase 2 Study of Depsipeptide in Patients With Relapsed or Refractory AML
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Romidepsin (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 19 Jan 2007 Status changed from recruiting
- 30 Aug 2005 New trial record.